558 related articles for article (PubMed ID: 23282228)
1. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis.
Abdel-Wahab AF; Fathy O; Al-Harizy R
Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
3. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
[TBL] [Abstract][Full Text] [Related]
4. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study.
Hassan AA; Habib HM; Eissa AA
Int J Rheum Dis; 2013 Jun; 16(3):319-24. PubMed ID: 23981754
[TBL] [Abstract][Full Text] [Related]
5. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
6. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
9. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
[TBL] [Abstract][Full Text] [Related]
10. Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?
Rezaieyazdi Z; Sahebari M; Hatef MR; Abbasi B; Rafatpanah H; Afshari JT; Esmaily H
Lupus; 2011 Dec; 20(14):1494-500. PubMed ID: 21993388
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.
Abbas D; Ezzat Y; Hamdy E; Gamil M
Lupus; 2012 Jan; 21(1):103-10. PubMed ID: 21976404
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
Mak A; Cheung BM; Mok CC; Leung R; Lau CS
Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
[TBL] [Abstract][Full Text] [Related]
16. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
17. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
[TBL] [Abstract][Full Text] [Related]
18. Peripheral vascular disease in systemic lupus patients.
June RR; Scalzi LV
J Clin Rheumatol; 2013 Oct; 19(7):367-72. PubMed ID: 24048099
[TBL] [Abstract][Full Text] [Related]
19. Serum fetuin-A levels are associated with carotid intima-media thickness in patients with normotensive chronic obstructive pulmonary disease.
Alpsoy S; Akyuz A; Mutlu LC; Oran M; Akkoyun DC; Topcu B; Degirmenci H; Guze S
Cardiol J; 2014; 21(2):191-7. PubMed ID: 23799555
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]